Ezb Diffuse Large B Cell Lymphoma C4725006
Ezb Diffuse Large B-Cell Lymphoma is an aggressive blood cancer affecting white blood cells. Treatment typically involves chemotherapy regimens, sometimes combined with immunotherapy or radiation.
Key facts at a glance
- ICD-10
- C83.37
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(oncologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Painless lymphadenopathy
(oncologic)Fever
(oncologic)Fatigue
(oncologic)Night sweats
(oncologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Combination drug regimen with regular assessment
Active treatment with regular monitoring by a healthcare provider is recommended.
R-CHOP immunochemotherapy
Combination of rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment for diffuse large B-cell lymphoma, targeting cancer cell proliferation and immune evasion.
Additional treatment options
Polatuzumab vedotin-based regimens
Antibody-drug conjugate therapy combined with chemotherapy for relapsed or refractory disease, delivering cytotoxic agents directly to CD79b-expressing lymphoma cells.
medicationRadiation therapy
Targeted external beam radiation for localized disease sites or consolidation after chemotherapy in aggressive lymphomas.
procedureAutologous stem cell transplantation
High-dose chemotherapy followed by rescue with patient's own stem cells for eligible patients with chemosensitive disease.
surgicalSurveillance imaging and PET-CT
Regular imaging studies to monitor treatment response and detect early relapse in patients achieving remission.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Ezb Diffuse Large B Cell Lymphoma C4725006?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Ezb Diffuse Large B Cell Lymphoma C4725006. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy